Xeomin

NDC 0259-1610 · Merz Pharmaceuticals, LLC

Generic nameincobotulinumtoxinA

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAMUSCULAR

Active ingredient(s)BOTULINUM TOXIN TYPE A

Strength100 [USP'U]/1

Pharmacologic classAcetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]

Marketing categoryBLA

Packages

0259-1610-01 — 1 VIAL, SINGLE-USE in 1 CARTON (0259-1610-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE

Billed under HCPCS

J0588 — Injection, incobotulinumtoxin a, 1 unit Medicare Part B payment limit (ASP + 6%): $5.29

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0023-1145 — onabotulinumtoxinA, 0023-3919 — onabotulinumtoxinA, 0023-3921 — onabotulinumtoxinA, 0023-9232 — onabotulinumtoxinA, 0259-1605 — incobotulinumtoxinA, 0259-1620 — incobotulinumtoxinA, 0259-4110 — incobotulinumtoxinA, 0259-4150 — incobotulinumtoxinA, 0299-5962 — Botulinum Toxin Type A, 15054-0500 — Botulinum Toxin Type A, 15054-0530 — Botulinum Toxin Type A, 46783-160 — incobotulinumtoxinA, 46783-161 — incobotulinumtoxinA, 46783-165 — incobotulinumtoxinA, 72301-595 — Prabotulinum Toxin Type A, 72960-112 — botulinum toxin type A, 85766-155 — onabotulinumtoxinA

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.